CelLBxHealth PLC (AIM:CLBX, FRA:DWV) has teamed up with The Royal Marsden to study a blood-based testing approach in 200 advanced lung cancer patients. The trial targets patients whose standard ctDNA tests return no actionable results, with findings expected by year end.
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) has struck a collaboration with Acuitas Therapeutics, the lipid nanoparticle specialist behind several leading COVID vaccines. Acuitas will fund the work itself, which Genflow says is a strong endorsement of its SIRT6 platform.
Active Energy Group PLC (AIM:AEG, OTCID:AEUSF) shares jumped 11% after its Ghummud site in the UAE was fully energised ahead of schedule. The two UAE sites are expected to generate around $2.6 million in annual revenue at steady state.
Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL, VFEX:CMCL) reported a weaker first quarter at its Blanket Mine in Zimbabwe, with gold output down to 14,767 ounces as planned. Full-year guidance of 72,000 to 76,500 ounces remains in place, with production weighted to the second half.
Great Southern Copper PLC (LSE:GSCU, FRA:E9E) has started drilling at its Piedras Blancas prospect in Chile, the first drill test of a porphyry copper target at the Especularita project. Three scout holes are underway, with encouraging surface chemistry already pointing to potential at depth.
Rome Resources PLC (AIM:RMR, FRA:33R) has raised £1.2 million from existing shareholders to fund drilling at Kalayi and test new targets at Mont Agoma in the DRC. Management bonuses are tied to landing a strategic partnership, keeping interests firmly in line with shareholders.
Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.
